Although drugs cannot cure tinnitus, there are a few that will help suppress the symptoms you are experiencing. Tricyclic antidepressants, like amitriptyline and nortriptyline, are two of the most commonly prescribed medications. If you are experiencing severe tinnitus, one of these drugs may be used. However, it's important to know that these medications may come with side effects such as dry mouth, blurry vision and heart issues. Discuss any other conditions you have or medications you are currently taking with your physician. Niravam and Xanax can also be prescribed, but each of these medications can cause drowsiness and nausea, and they can be habit-forming.
Some people experience a sound that beats in time with their pulse, known as pulsatile tinnitus or vascular tinnitus. Pulsatile tinnitus is usually objective in nature, resulting from altered blood flow, increased blood turbulence near the ear, such as from atherosclerosis or venous hum, but it can also arise as a subjective phenomenon from an increased awareness of blood flow in the ear. Rarely, pulsatile tinnitus may be a symptom of potentially life-threatening conditions such as carotid artery aneurysm or carotid artery dissection. Pulsatile tinnitus may also indicate vasculitis, or more specifically, giant cell arteritis. Pulsatile tinnitus may also be an indication of idiopathic intracranial hypertension. Pulsatile tinnitus can be a symptom of intracranial vascular abnormalities and should be evaluated for irregular noises of blood flow (bruits).
In persons with pulsatile tinnitus, additional tests maybe proposed to study the blood vessels and to check the pressure inside the head. Gentle pressure on the neck can be performed to block the jugular vein but not the carotid artery. The Valsalva maneuver reduces venous return by increasing intrathoracic pressure. If there is a venous hum, this usually abates or improves markedly. If the pulsation is arterial, these tests have no effect.
^ Langguth B, Goodey R, Azevedo A, et al. (2007). "Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006". Tinnitus: Pathophysiology and Treatment. Progress in Brain Research. 166. pp. 525–36. doi:10.1016/S0079-6123(07)66050-6. ISBN 978-0444531674. PMC 4283806. PMID 17956816.
Like Shore and Kilgard’s work, most of the promising research on tinnitus has to do with stimulating or altering the brain’s hyperactivity in ways that reduce tinnitus. Some studies have shown electromagnetic brain stimulation — using either invasive or noninvasive techniques, including procedures that involve surgically implanted electrodes or scalp electrodes — may help reverse a patient’s tinnitus. (6) While none of these treatment options are currently available, all have shown some success in treating the condition.
Until recently, most tinnitus patients had little reason to believe doctors would ever be able to completely cure or reverse the affliction. Drug therapies had consistently failed, and so had more invasive procedures — including some surgeries to remove the auditory nerve that transmits sound from the ear to the brain, according to past research. (1,2)
As an initial test of our treatment, we first conducted a small pilot study to see if there were measurable benefits within 3 to 6 months of using this therapy. While we did not inform participants of whether they would receive a treatment or unaltered music, every participant in fact received a treatment. Participants reported a drop in scores on the Tinnitus Handicap Inventory (THI) within 3 months of using their personalized sound therapy for about 2 hours a day. THI is a psychometrically robust and validated questionnaire that assesses the impact of tinnitus on daily living and the degree of distress suffered by the tinnitus patient. Furthermore, we saw increased benefits after 6 months of treatment use (Figure 1). This data suggested that our treatment may be engaging brain plasticity in a positive manner, thereby gradually reducing tinnitus over time. Armed with this information, we designed a more rigorous trial that is very uncommon among research in tinnitus therapies.
All materials posted on the ATA website are subject to copyright owned by the American Tinnitus Association (ATA). No part of these pages, either text, file or image may be used for any purpose other than personal use. Any reproduction, retransmissions, republication, storage in a retrieval system or retransmission, in any form or by any means, electronic, mechanical or otherwise, is strictly prohibited without prior written permission. Submit our contact form for general inquiries.